A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

Joseph Zohar, Stephen Stahl, Hans Jurgen Moller, Pierre Blier, David Kupfer, Shigeto Yamawaki, Hiroyuki Uchida, Michael Spedding, Guy M. Goodwin, David Nutt

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

Original languageEnglish
Pages (from-to)2318-2325
Number of pages8
JournalEuropean Neuropsychopharmacology
Volume25
Issue number12
DOIs
Publication statusPublished - 2015 Dec 1

Keywords

  • Adherence
  • Mode of action
  • Neuroscience
  • Nomenclature
  • Pharmacological domain
  • Psychotropic drugs

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature'. Together they form a unique fingerprint.

  • Cite this

    Zohar, J., Stahl, S., Moller, H. J., Blier, P., Kupfer, D., Yamawaki, S., Uchida, H., Spedding, M., Goodwin, G. M., & Nutt, D. (2015). A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature. European Neuropsychopharmacology, 25(12), 2318-2325. https://doi.org/10.1016/j.euroneuro.2015.08.019